CClinicalTrials.gg
CompletedNCT07689396Updated Aug 31, 2026

Predictors of Treatment Expectations in Myofascial Pain Syndrome

An observational study in Myofascial Pain Syndromes, sponsored by KTO Karatay University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by KTO Karatay University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
97
Ages
18 Years and older
Sex
All
01

Study summary

This cross-sectional study aims to determine the predictors of treatment expectations in individuals with myofascial pain syndrome (MPS). MPS is one of the most common causes of musculoskeletal pain and is associated with reduced quality of life. Patients' pre-treatment expectations are known to influence clinical outcomes, yet the factors that predict these expectations have not been established. Adults diagnosed with MPS who are scheduled to receive physiotherapy complete measures of treatment expectations, pain intensity and duration, health-related quality of life, and fatigue. Multiple regression analysis is used to examine the extent to which pain intensity, pain duration, quality of life, and fatigue predict treatment expectations.

Read the detailed description

Design and setting: Cross-sectional, descriptive study conducted at a private physiotherapy clinic in Konya, Turkiye, between April and August 2026.

Participants: Adults (18 years and older) with a diagnosis of MPS, a pain intensity of at least 3 on a visual analog scale, and scheduled to receive at least two weeks of physiotherapy. Individuals with a psychiatric diagnosis, a chronic systemic disease, or any barrier preventing communication are excluded.

Sample size: Based on an a priori power analysis (G*Power; effect size 0.15, power 0.80, alpha 0.05), a minimum of 85 participants is required.

Measures: A personal information form; the Treatment Expectation Questionnaire (TEX-Q), Turkish version, as the dependent variable; pain intensity and duration via a visual analog scale; health-related quality of life via the Short Form-36 (SF-36); and fatigue via the Brief Fatigue Inventory (BFI).

Analysis: Descriptive statistics, the Shapiro-Wilk test for normality, and multiple linear regression models (with 95% confidence intervals) to examine the associations between treatment expectations and pain intensity, pain duration, quality of life, and fatigue. Statistical significance is set at p\<0.05.

02

Conditions studied

  • Myofascial Pain Syndromes

Keywords

  • pain
  • myofascial pain syndrome
  • treatment expectation
  • quality of life
  • fatigue
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 97 is close to the median of 90 across 181 observational studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

KTO Karatay University is the lead sponsor of 126 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults (18 years and older) diagnosed with myofascial pain syndrome who present to a private physiotherapy clinic in Konya, Turkiye and are scheduled to receive at least two weeks of physiotherapy.

Inclusion criteria

  • Age 18 years and older
  • Diagnosis of myofascial pain syndrome
  • Pain intensity of at least 3 on the Visual Analog Scale
  • Scheduled to receive at least two weeks of physiotherapy

Exclusion criteria

Exclusion Criteria:

  • Diagnosed psychiatric disorder
  • Chronic systemic disease
  • Any barrier preventing communication
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
97 participants (actual)
Patient registry
No

Groups and cohorts

  • Individuals with myofascial pain syndrome

    Adults with a diagnosis of myofascial pain syndrome presenting to a private physiotherapy clinic and scheduled to receive at least two weeks of physiotherapy. Treatment expectations and candidate predictors are assessed once at enrollment.

06

What researchers measure

Primary outcomes

  1. Treatment expectations

    Measured with the Treatment Expectation Questionnaire (TEX-Q), Turkish version. The total score of the first 15 items ranges from 0 to 150, with higher scores indicating greater treatment expectations.

    Time frame: At enrollment, before the physiotherapy program (single cross-sectional assessment)

Secondary outcomes

  1. Pain intensity

    Assessed with a 10 cm Visual Analog Scale (VAS) for rest, activity, and night pain; 0 = no pain, 10 = unbearable pain.

    Time frame: At enrollment (single cross-sectional assessment)

  2. Pain duration

    Self-reported duration of pain complaints, recorded in weeks.

    Time frame: At enrollment (single cross-sectional assessment)

  3. Health-related quality of life

    Assessed with the Short Form-36 (SF-36). Subscale scores range from 0 to 100, with higher scores indicating better health status.

    Time frame: At enrollment (single cross-sectional assessment)

  4. Fatigue

    Assessed with the Brief Fatigue Inventory (BFI); higher scores indicate greater fatigue.

    Time frame: At enrollment (single cross-sectional assessment)

07

Study locations

1 site
  • KTO Karatay University
    Konya, Turkey (Türkiye)
08

References and documents

Publications

  • Cakir F, Gercek H, Ozturk S, Kuru Colak T, Sari Z, Polat MG. The Treatment Expectation Questionnaire Tool: A Cross-Cultural Adaptation and Psychometric Evaluation in Turkey. Eval Health Prof. 2025 Sep;48(3):300-307. doi: 10.1177/01632787241268211. Epub 2024 Jul 26. PubMed 39056487 ↗
  • Alberts J, Lowe B, Glahn MA, Petrie K, Laferton J, Nestoriuc Y, Shedden-Mora M. Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews. BMJ Open. 2020 Aug 20;10(8):e036169. doi: 10.1136/bmjopen-2019-036169. PubMed 32819942 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07689396
Lead sponsor
KTO Karatay University
Responsible party
Hasan Gerçek (Assistant Professor, KTO Karatay University) — Principal investigator
First posted
Jul 8, 2026
Start date
Jul 1, 2026
Primary completion
Aug 28, 2026
Completion
Aug 28, 2026
Last update
Aug 31, 2026

Study contacts

Hasan Gercek, PT, PhD
principal investigator · KTO Karatay University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion